Asis Sethi | Material Science | Best Researcher Award 

Published on by Network Science

Mr. Asis Sethi | Material Science | Best Researcher Award 

CSIR-Central Electrochemical Research Institute | India

Author Profiles

Scopus

Orcid ID

Google Scholar

Early Academic Pursuits

Mr. Asis Sethi began his academic journey with a Bachelor of Science degree in Chemistry from Ravenshaw University, Cuttack (2013–2016), where he developed a strong foundation in chemical sciences. His quest for deeper knowledge led him to pursue a Master of Science in Chemistry at Pondicherry University (2016–2018), one of India’s premier institutions. Building upon his academic excellence, he embarked on a Doctor of Philosophy (Ph.D.) in Chemical Science at CSIR–Central Electrochemical Research Institute (CECRI), Karaikudi, in 2019, where his research is centered on advanced electrochemical energy storage technologies.

Professional Endeavors

Currently serving as an Assistant Professor in the Department of Chemistry at Bhadrak Autonomous College under the Department of Higher Education, Odisha (since 2024), Mr. Sethi has committed himself to both teaching and research. His dual role as an educator and researcher enables him to inspire young learners while advancing scientific frontiers in electrochemistry and energy storage. His early recognition as a CSIR-NET/JRF awardee in June 2018 further highlights his academic potential and research capability.

Contributions and Research Focus

Mr. Sethi’s research contributions lie at the intersection of material science, electrochemistry, and sustainable energy. His core research focuses on the design and development of next-generation aqueous batteries, dual ion batteries, zinc-ion batteries, and redox flow systems. His expertise also extends to the synthesis of transition-metal–based materials, development of electrolytes including water-in-salt systems, and advanced cell configurations such as Swagelok, flooded, pouch, and coin cells. His work integrates experimental design with computational insights to address real-world challenges in energy storage and conversion.

Impact and Influence

Through his active participation in national and international conferences, Mr. Sethi has disseminated his findings to a wider scientific audience. He has presented oral talks and posters at IIT Delhi, SRM Institute of Science and Technology, and CSIR-CECRI, as well as representing CSIR at the India International Science Festival (2022). His research has not only enriched the academic community but also contributed to the development of practical solutions in clean energy technologies. His publication record in reputed international journals such as Chemical Communications, Journal of Materials Chemistry A, ChemPhysChem, Batteries & Supercaps, and International Journal of Hydrogen Energy reflects the depth and significance of his scholarly output.

Academic Citations

Mr. Sethi’s research publications are already receiving attention in the scholarly community, evident from his articles featured in high-impact journals, including a cover feature in ChemPhysChem (2023). These citations demonstrate the academic visibility and influence of his work in advancing electrolyte design and energy storage mechanisms. His collaborations with national and international researchers further broaden the scope and recognition of his contributions.

Legacy and Future Contributions

As a young researcher and educator, Mr. Sethi stands at the forefront of sustainable energy research. His pioneering studies on electrolyte modifications, ion storage mechanisms, and electrode material design hold promise for the development of safer, cost-effective, and eco-friendly batteries. Going forward, he is poised to mentor future researchers, expand his publication portfolio, and contribute significantly to India’s scientific progress in renewable energy and electrochemical storage technologies.

Conclusion

In summary, Mr. Asis Sethi exemplifies the qualities of a dedicated academic, an innovative researcher, and an inspiring mentor. His strong educational foundation, impactful research contributions, and growing academic recognition position him as a valuable asset to the scientific and educational community. With his ongoing commitment to advancing electrochemical energy storage, he is well-suited for recognition such as the Best Researcher Award, underscoring his potential to shape the future of sustainable energy solutions.

Notable Publications

“Strategies for electrolyte modification in aqueous zinc-ion batteries: an antisolvent approach" 

  • Author: Asis Sethi; Chaithra Rajeev; Anil Kumar U.; Jefin F.; Santoshkumar D. Bhat; Vishal M. Dhavale
  • Journal: Chemical Communications
  • Year: 2025

"Tailored concave platinum nanocrystals for the selective electro-oxidation of formic acid" 

  • Author: Chaithra Rajeev; Anil Kumar U.; Asis Sethi; L. Muhammed Shahid; Vishal M. Dhavale‏
  • Journal: New Journal of Chemistry
  • Year: 2025

"Effect of Anions in Zn‐Based Aqueous Electrolyte on Electrochemical Performance of Prussian Blue Analogue" 

  • Author: Asis Sethi; Chaithra Rajeev; Anil Kumar U.; Parul Sharma; Anurag Prakash Sunda; Vishal M. Dhavale
  • Journal: Batteries & Supercaps
  • Year: 2025

"Assessing the impact of an antisolvent-regulated ZnCl2 water-in-salt electrolyte on solvation structure: a multiscale computational validation for aqueous Zn-ion battery application" 

  • Author: Asis Sethi; Chaithra Rajeev; Anil Kumar U.; Parul Sharma; Anurag Prakash Sunda; Vishal M. Dhavale‏
  • Journal: Journal of Materials Chemistry A‏
  • Year: 2024

"Special tailoring of a copper–pyromellitic acid complex with sulfonated poly(ether ether ketone) to form a composite membrane for polymer electrolyte fuel cells" 

  • Author: Anil Kumar U.; Rajendran Sakthivel; Asis Sethi; Baskaran Mohan Dass; Santoshkumar D. Bhat; Vishal M. Dhavale
  • Journal: New Journal of Chemistry
  • Year: 2023

 

Jianxun Qi | Biological Networks | Best Researcher Award

Published on by Network Science

Dr. Jianxun Qi | Biological Networks | Best Researcher Award

Institute of Microbiology, Chinese Academy of Sciences | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Jianxun Qi laid a strong academic foundation in microbiology and virology, which paved the way for his remarkable contributions to structural biology and protein chemistry. His early focus was on understanding virus–host interactions, a field that would later define his scientific career and global recognition.

Professional Endeavors

Currently serving as a Professor at the Institute of Microbiology, Chinese Academy of Sciences (IMCAS), Dr. Qi has established himself as a leading scientist in viral pathogenesis and structural virology. In 2021, he was selected as a leading talent in science and technology innovation under China’s prestigious “Ten Thousand Talent Program.” His professional trajectory reflects dedication to advancing viral immunology and translational research with broad societal impact.

Contributions and Research Focus

Dr. Qi’s work centers on deciphering the structural mechanisms of virus–receptor interactions, shedding light on the molecular dynamics of pathogens such as Influenza virus, Coronaviruses, Ebola virus, Thogotovirus, ASFV, Coxsackievirus A10, and SFTSV. Through high-impact publications in Science, Nature, Cell, EMBO, PNAS, and Nature Communications, he has provided pivotal insights into viral entry, immune evasion, and vaccine design. Recent studies extend his expertise to epitope-based vaccine development and broad-spectrum antiviral engineering, offering innovative approaches to combat emerging infectious diseases.

Impact and Influence

With over 19,000 citations and an H-index of 64, Dr. Qi’s research has had a profound influence on the global scientific community. His findings have shaped understanding of pandemic threats, including MERS-CoV, SARS-CoV-2, and Ebola virus, directly informing vaccine strategies and therapeutic interventions. His recognition as a Highly Cited Researcher (2021–2024) and inclusion in Stanford University and Elsevier’s World’s Top 2% Scientists List underscore his international impact.

Academic Citations and Recognition

Dr. Qi’s groundbreaking studies—such as structural revelations on Influenza H7N9 (Science, 2013), MERS-CoV (Nature, 2013), and SARS-CoV-2 (Cell, 2020, 2022)—are extensively cited worldwide. His pioneering discoveries have garnered major honors, including the First Prize of the Beijing Science and Technology Award (2011) and the First Prize of the Chinese Preventive Medicine Association Science and Technology Award (2017).

Legacy and Future Contributions

Dr. Qi’s legacy lies in bridging fundamental virology with translational medicine, guiding the development of next-generation vaccines and antivirals. His continued exploration of viral mechanisms, coupled with collaborative innovations such as epitope vaccines and monoclonal antibody studies, positions him to contribute further to global preparedness against pandemics. Looking ahead, his research promises to expand the frontiers of viral immunology and structural vaccinology.

Conclusion

Dr. Jianxun Qi exemplifies scientific excellence through his persistent pursuit of knowledge, impactful research, and leadership in microbiology. His influential work on virus–host interactions and vaccine innovation has not only advanced academic discourse but also delivered tangible benefits to public health. As he continues to push boundaries in virology and immunology, his contributions will remain a cornerstone for future breakthroughs in infectious disease prevention and control.

Notable Publications

"T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots" 

"Enabling the immune escaped etesevimab fully-armed against SARS-CoV-2 Omicron subvariants including KP.2" 

  • Journal: Hlife
  • Citation: 5
  • Year: 2025

"Structural basis of DNA replication fidelity of the Mpox virus" 

"Precise motif and cross-presentation of coronavirus peptides by feline MHC class I: implications for the mild infection of SARS-CoV-2" 

"Molecular mechanism of potently neutralizing human monoclonal antibodies against severe fever with thrombocytopenia virus infection" 

 

Cora Sternberg | Meta analysis | Outstanding Scientist Award

Published on by Network Science

Dr. Cora Sternberg | Meta analysis | Outstanding Scientist Award

Weill Cornell Medicine | United States

Author Profiles

Scopus

Orcid ID

Google Scholar

Early Academic Pursuits

Dr. Cora Sternberg’s academic journey reflects her commitment to excellence from the outset. She completed her medical training with distinction and pursued advanced fellowships, including a Research Fellowship in Immunology at the National Institutes of Health (1976–1977). Her early academic roles as Teaching Assistant at Stanford and Mount Sinai, followed by Clinical Instructor at Cornell University, laid the foundation for her lifelong dedication to education and clinical research. Her Phi Beta Kappa distinction from the University of Pennsylvania marked the start of a career dedicated to innovation and leadership in oncology.

Professional Endeavors

Over four decades, Dr. Sternberg has held prestigious academic and clinical leadership roles. She was Chief of Medical Oncology at San Camillo-Forlanini Hospital in Rome and served as Professor at La Sapienza University, shaping Italy’s oncology community. Since 2018, she has been Professor of Medicine and Clinical Director of the Englander Institute for Precision Medicine at Weill Cornell Medicine and New York-Presbyterian. She has also served as a global faculty member at Temple University, Tufts University, and European institutions.

Contributions and Research Focus

Dr. Sternberg has pioneered groundbreaking research in prostate cancer, bladder cancer, and renal cell carcinoma. She was instrumental in developing practice-changing therapies such as abiraterone, enzalutamide, and darolutamide, significantly improving survival outcomes for prostate cancer patients. Her work in urothelial cancer led to the establishment of M-VAC chemotherapy and global adoption of immunotherapy protocols. She also contributed to the development of pazopanib and other targeted therapies in renal cell carcinoma. Recently, she has expanded her research focus to artificial intelligence in oncology, spearheading initiatives to integrate AI into therapeutic decision-making.

Impact and Influence

With over 546 publications, six textbooks, and more than 45,200 citations, Dr. Sternberg ranks among the World’s Top 2% Scientists (Stanford University) and the top 5% in the Doximity community for citations. She has delivered more than 835 lectures worldwide, influencing clinical practice, policy, and guidelines in oncology. Her leadership roles in international organizations such as ASCO, ESMO, ECCO, and EORTC demonstrate her far-reaching influence.

Academic Citations

Dr. Sternberg’s research impact is widely recognized. Her publications in high-impact journals such as New England Journal of Medicine, Lancet Oncology, and Journal of Clinical Oncology have shaped global treatment standards. Her works are consistently cited in clinical guidelines, trial protocols, and oncology education, affirming her stature as a thought leader in medical oncology.

Legacy and Future Contributions

Dr. Sternberg’s legacy lies not only in transformative research but also in mentorship. She has nurtured generations of oncologists, fostering innovation and translational research. Currently, she co-leads the Career Development Program in the Bladder SPORE initiative, ensuring the pipeline of future oncology leaders. Her pioneering role in AI in oncology positions her to continue shaping the future of precision medicine, bridging clinical care with technological innovation.

Conclusion

Dr. Cora Sternberg exemplifies the qualities of an Outstanding Scientist—visionary leadership, transformative research, global influence, and unwavering dedication to advancing oncology. Her lifelong contributions to clinical practice, groundbreaking research, academic mentorship, and adoption of emerging technologies ensure her lasting impact on the medical community and future generations of scientists.

Notable Publications

"Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100" 

  • Author: homas Powles; Srikala S. Sridhar; Joaquim Bellmunt; Cora N. Sternberg; Petros Grivas; Ewan Hunter; Matthew Salter; Ryan Powell; Ann Dring; Jayne Green et al.
  • Journal: Cancers
  • Year: 2025

"The Use of Artificial Intelligence for Cancer Therapeutic Decision-Making" 

  • Author: Olivier Elemento; Sean Khozin; Cora N. Sternberg
  • Journal: NEJM AI
  • Year: 2025

"Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100" 

  • Author: Thomas Powles; Srikala S. Sridhar; Joaquim Bellmunt; Cora N. Sternberg; Petros Grivas; Ewan Hunter; Matthew Salter; Ryan Powell; Ann Dring; Jayne Green et al.
  • Journal: Preprint
  • Year: 2025

"Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591" 

  • Author: Scott T. Tagawa; Charlene Thomas; A. Oliver Sartor; Michael Sun; Judith Stangl-Kremser; Mahelia Bissassar; Shankar Vallabhajosula; Sandra Huicochea Castellanos; Jones T. Nauseef; Cora N. Sternberg et al.
  • Journal: Journal of Clinical Oncology
  • Year: 2024

"Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial" 

  • Author: Maha Hussain; Bertrand Tombal; Fred Saad; Karim Fizazi; Cora N. Sternberg; E. David Crawford; Neal Shore; Evgeny Kopyltsov; Arash Rezazadeh Kalebasty; Martin Bögemann et al.
  • Journal: Journal of Clinical Oncology
  • Year: 2023